Skip to Main Content

Paper Details

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).
Am Heart J
22
2018
CYP2C19, CYP2C19*2, Clopidogrel, DNA samples, P2Y12, P2Y12 receptor, Platelet, acute coronary syndrome, adenosine diphosphate, atherothrombotic events, clopidogrel, ischemic stroke, patient, patients, platelet
Author NameAffiliation
Ruth E PakyzUniversity of Maryland School of Medicine
Ruth E PakyzUniversity of Maryland School of Medicine
Li GongStanford University
Joshua P LewisUniversity of Maryland School of Medicine
Eun Young KimInje University Busan Paik Hospital
Dan M RodenVanderbilt University School of Medicine
Russ B AltmanStanford University
Michiaki KuboRIKEN Center for Integrative Medical Sciences
Braxton D MitchellUniversity of Maryland, Education and Clinical Center, Veterans Affairs Medical Center
Matthias SchwabStuttgart and University of Tubingen, University Hospital
Marylyn D Ritchie
Marylyn D Ritchie
Teri E KleinStanford University
Alan R ShuldinerUniversity of Maryland School of Medicine
Alan R ShuldinerUniversity of Maryland School of Medicine
  • 1 - 15

Datasets

Release 1.2